Insider Transactions in Q2 2023 at Cyclacel Pharmaceuticals, Inc. (CYCC)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jun 30 2023	Brian Schwartz Interim Chief Medical Officer	BUY Grant, award, or other acquisition	Direct	21,219 +34.32%	-
Jun 30 2023	Christopher S Henney Director	BUY Grant, award, or other acquisition	Direct	21,219 +35.0%	-
Jun 30 2023	Kenneth M. Ferguson Director	BUY Grant, award, or other acquisition	Direct	21,219 +32.07%	-
Jun 30 2023	Karin L Walker Director	BUY Grant, award, or other acquisition	Direct	21,219 +34.32%	-
Jun 30 2023	Robert J. Spiegel Director	BUY Grant, award, or other acquisition	Direct	21,219 +35.0%	-
Jun 30 2023	Sam L Barker Director	BUY Grant, award, or other acquisition	Direct	21,219 +34.43%	-

Receive a notification when an Institution or Guru buys or sells CYCC shares.

Notify only if

Value

Get notified when an Cyclacel Pharmaceuticals, Inc. insider buys or sells CYCC shares.

Notify only if

Operation

Value

Type

Receive news related to Cyclacel Pharmaceuticals, Inc.